BioCryst Pharmaceuticals
BCRX
8.40
+0.45
+5.66%
BioCryst Pharmaceuticals
US · BCRX
#2766 by market cap
Listed 1970
8.40
+0.45
+5.66%
Live - 5344 symbols - heartbeat 61s ago
· 2026-10-08 07:55
Pre-market
8.54
+1.67%
After-hours
8.38
-0.24%
- Market cap
- 2.15B
- P/E (TTM)i
- -6.00
- P/Bi
- -4.72
- EPSi
- 1.21
- Div yieldi
- 0.00%
- 52W posi
- 46%
Reader sentiment
Are you bullish or bearish on BCRX?
Anonymous reader poll. Unscientific, not investment advice.
About BioCryst Pharmaceuticals
BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.
- Founded
- 1986
- CEO
- Mr. Charles K. Gayer
- Employees
- 435
- Headquarters
- Durham, North Carolina, United States of America
- Fiscal year end
- 12-31
- Website
- biocryst.com
Company profile
- Exchange
- US
- Symbol
- BCRX
- Market-cap rank
- #2766
- Listing date
- 1970-01-01
- Market cap
- 2.15B
- Float cap
- 1.87B
- Shares out
- 255.54M
- Float shares
- 222.32M
Sectors & themes
Drug Manufacturers - Specialty & Generic
Fractional Shares JP
Quote time 2026-10-08 07:55:47 · For reference only, not investment advice and not tailored to your situation.